AMBP

alpha-1-microglobulin/bikunin precursor, the group of Lipocalins

Basic information

Region (hg38): 9:114060127-114078328

Previous symbols: [ "ITI", "ITIL" ]

Links

ENSG00000106927NCBI:259OMIM:176870HGNC:453Uniprot:P02760AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AMBP gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMBP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
28
clinvar
5
clinvar
33
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 28 5 0

Variants in AMBP

This is a list of pathogenic ClinVar variants found in the AMBP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-114060270-C-T not specified Uncertain significance (Feb 28, 2024)3114650
9-114060930-C-T not specified Uncertain significance (Nov 08, 2022)2323720
9-114060951-C-G not specified Uncertain significance (May 18, 2023)2519771
9-114060974-C-A not specified Uncertain significance (Sep 14, 2022)2312009
9-114060987-C-T not specified Uncertain significance (Oct 17, 2023)3114729
9-114061068-G-A not specified Uncertain significance (Apr 13, 2023)2511907
9-114061071-C-G not specified Uncertain significance (Jan 03, 2024)3114719
9-114061089-T-G not specified Uncertain significance (Mar 07, 2024)3114716
9-114061098-G-A not specified Uncertain significance (Jul 19, 2023)2594047
9-114061451-C-G not specified Uncertain significance (Jun 03, 2022)2293581
9-114061475-C-T Likely benign (Apr 01, 2022)2659437
9-114061493-C-T not specified Uncertain significance (May 24, 2023)2513160
9-114061571-A-C not specified Likely benign (Jan 16, 2024)3114707
9-114062688-G-T not specified Uncertain significance (May 26, 2024)3292312
9-114069712-G-A not specified Uncertain significance (Aug 02, 2022)2407133
9-114072919-A-G Benign (Dec 11, 2017)713724
9-114072927-C-T not specified Uncertain significance (Nov 09, 2021)2334497
9-114072928-G-C not specified Uncertain significance (Sep 16, 2021)3114686
9-114072936-A-G not specified Uncertain significance (Dec 20, 2023)3114682
9-114074065-T-C not specified Uncertain significance (May 26, 2022)2230240
9-114074068-T-C not specified Likely benign (Jun 02, 2023)2555531
9-114074069-G-A not specified Uncertain significance (Dec 26, 2023)3114674
9-114074128-T-C not specified Uncertain significance (Feb 01, 2023)2472326
9-114076604-C-T not specified Likely benign (Jul 26, 2023)2614542
9-114076638-C-T not specified Uncertain significance (Mar 14, 2023)2454902

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AMBPprotein_codingprotein_codingENST00000265132 1018346
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.79e-130.038512562201261257480.000501
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1622282211.030.00001322292
Missense in Polyphen7982.8430.95361927
Synonymous0.5238187.20.9290.00000554680
Loss of Function0.2322021.20.9460.00000112226

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001300.00129
Ashkenazi Jewish0.000.00
East Asian0.0003810.000381
Finnish0.00004630.0000462
European (Non-Finnish)0.0004750.000457
Middle Eastern0.0003810.000381
South Asian0.0008510.000850
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Inter-alpha-trypsin inhibitor inhibits trypsin, plasmin, and lysosomal granulocytic elastase. Inhibits calcium oxalate crystallization. {ECO:0000269|PubMed:7676539}.;
Pathway
Vesicle-mediated transport;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors (Consensus)

Recessive Scores

pRec
0.343

Intolerance Scores

loftool
0.564
rvis_EVS
-0.49
rvis_percentile_EVS
22.65

Haploinsufficiency Scores

pHI
0.321
hipred
N
hipred_score
0.254
ghis
0.922

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.956

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ambp
Phenotype
reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
ambp
Affected structure
eye
Phenotype tag
abnormal
Phenotype quality
decreased size

Gene ontology

Biological process
receptor-mediated endocytosis;cell adhesion;female pregnancy;negative regulation of endopeptidase activity;viral process;protein-chromophore linkage;protein catabolic process;heme catabolic process;negative regulation of JNK cascade;negative regulation of immune response
Cellular component
extracellular region;extracellular space;plasma membrane;cell surface;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome;blood microparticle
Molecular function
serine-type endopeptidase inhibitor activity;protein binding;calcium channel inhibitor activity;IgA binding;heme binding;protein homodimerization activity;calcium oxalate binding